Prion infectivity in variant Creutzfeldt-Jakob disease rectum

Gut

Volumn 56, Issue 1, 2007, Pages 90-94

  Wadsworth, J D F ^a   Joiner, S ^a   Fox, K ^a   Linehan, J M ^a   Desbruslais, M ^a   Brandner, S ^a   Asante, E A ^a   Collinge, J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INOCULATION; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BRAIN; CREUTZFELDT-JAKOB SYNDROME; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; PRIONS; PRPC PROTEINS; PRPSC PROTEINS; RECTUM;

EID: 33845979521     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.091637     Document Type: Article

References (33)

1. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 1999;354:317-23.
2. Hilton DA, Ghani AC, Conyers L, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004;203:733-9.
3. Frosh A, Smith LC, Jackson CJ, et al. Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet 2004;364:1260-2.
4. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-9.
5. Wadsworth JDF, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immuno-blotting assay. Lancet 2001;358:171-80.
6. Hilton DA, Sutak J, Smith ME, et al. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 2004;57:300-2.
7. Head MW, Ritchie D, Smith N, et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 2004; 164:143-53.
8. Joiner S, Linehan JM, Brandner S, et al. High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease. Gut 2005;54:1506-8.
9. Bramble MG, Ironside JW. Creutzfeldt-Jakob disease: implications for gastroenterology. Gut 2002;50:888-90.
10. Jackson GS, McKintosh E, Flechsig E, et al. An enzyme-detergent method for effective prion decontamination of surgical steel. J Gen Virol 2005;86:869-78.
11. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21.
12. Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-9.
13. Flechsig E, Hegyi I, Enari M, et al. Transmission of scrapie by steel-surface-bound prions. Mol Med 2001;7:679-84.
14. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001;24:519-50.
15. Asante EA, Linehan JM, Desbruslais M, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002;21:6358-66.
16. Bruce ME, McConnell I, Will RG, et al. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001;358:208-9.
17. Glatzel M, Abela E, Maissen M, et al. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003;349:1812-20.
18. Griffith JS. Self replication and scrapie. Nature 1967;215:1043-4.
19. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982;216:136-44.
20. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998;95:13363-83.
21. Collinge J, Palmer MS, Sidle KCL, et al. Transmission of fatal familial insomnia to laboratory animals. Lancet 1995;346:569-70.
22. Lasmezas CI, Deslys J-P, Robain O, et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997;275:402-5.
23. Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997;389:448-50.
24. Prusiner SB. Molecular biology of prion diseases. Science 1991;252:1515-22.
25. Wadsworth JDF, Asante EA, Desbruslais M, et al. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 2004;306:1793-6.
26. Carlson GA, Kingsbury DT, Goodman PA, et al. Linkage of prion protein and scrapie incubation time genes. Cell 1986;46:503-11.
27. Joiner S, Linehan J, Brandner S, et al. Irregular presence of abnormal prion protein in appendix in variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2002;73:597-8.
28. Kascsak RJ, Rubenstein R, Merz PA, et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 1987;61:3688-93.
29. Sc molecules with different conformations. Nat Med 1998;4:1157-65.
30. Ironside JW, Head MW, Bell JE, et al. Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 2000;37:1-9.
31. Prusiner SB, Cochran SP, Groth DF, et al. Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 1982;11:353-8.
32. Flechsig E, Shmerling D, Hegyi I, et al. Prion protein devoid of the octopeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 2000;27:399-408.
33. Axon AT, Beilenhoff U, Bramble MG, et al. Variant Creutzfeldt-Jakob disease (vCJD) and gastrointestinal endoscopy. Endoscopy 2001;33: 1070-80.